Artwork

Sisällön tarjoaa Grant Stevens. Grant Stevens tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Ep. 106 - Conor Gallagher on Building a Biotech Pipeline for Aesthetics and Therapeutics

38:43
 
Jaa
 

Manage episode 436530056 series 3462066
Sisällön tarjoaa Grant Stevens. Grant Stevens tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

As the Chief Scientific Officer at Revance, Conor Gallagher spearheads R&D, process and analytical development under the umbrella of scientific innovation while also leading a team working on Revance's biosimilar program.
With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to adapt to dynamic facial movements for natural-looking results, and Daxxify, a long-lasting/fast-acting neurotoxin for smoothing frown lines that is powered by a novel peptide. What's more, Daxxify was recently approved for FDA approved for the treatment of cervical dystonia in adults.
And the future is looking even brighter with the recent announcement that Revance has entered into a merger agreement with Crown Laboratories to bring together their complementary product lines to create a leading, innovative, high-growth aesthetics and skincare company.
So tune in for a sneak peek at what's next in the biotech pipeline at Revance — and soon to be Crown Laboratories — on the latest episode of The Technology of Beauty.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

  continue reading

102 jaksoa

Artwork
iconJaa
 
Manage episode 436530056 series 3462066
Sisällön tarjoaa Grant Stevens. Grant Stevens tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

As the Chief Scientific Officer at Revance, Conor Gallagher spearheads R&D, process and analytical development under the umbrella of scientific innovation while also leading a team working on Revance's biosimilar program.
With the stated goal of setting a "new standard in healthcare by elevating patient and physician experiences," Revance boasts an impressive lineup of aesthetic and therapeutic offerings. Notable among these are the RHA Collection of dermal fillers, designed to adapt to dynamic facial movements for natural-looking results, and Daxxify, a long-lasting/fast-acting neurotoxin for smoothing frown lines that is powered by a novel peptide. What's more, Daxxify was recently approved for FDA approved for the treatment of cervical dystonia in adults.
And the future is looking even brighter with the recent announcement that Revance has entered into a merger agreement with Crown Laboratories to bring together their complementary product lines to create a leading, innovative, high-growth aesthetics and skincare company.
So tune in for a sneak peek at what's next in the biotech pipeline at Revance — and soon to be Crown Laboratories — on the latest episode of The Technology of Beauty.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

  continue reading

102 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas